Bill > S723

This bill, the Access to Prescription Digital Therapeutics Act of 2023, seeks to amend the Social Security Act to provide coverage and payment for prescription digital therapeutics (PDTs) under the Medicare and Medicaid programs. PDTs are defined as FDA-cleared or approved products, devices, internet applications, or other technologies that primarily use software to prevent, manage, or treat medical conditions. The bill requires the Secretary of Health and Human Services to establish a payment methodology and coding system for PDTs, and mandates manufacturers to report information on payment rates, distribution volumes, and user numbers to the Secretary. The bill also includes Medicaid coverage provisions for PDTs.